Medscape

FDA grants 510(k) clearance to Cordis to market retrievable vena cava filter

Warren, NJ - The Food and Drug Administration has granted 510(k) clearance to Cordis Endovascular to market the OPTEASE TM vena cava retrievable filter. The filter is designed to be percutaneously ...
Medscape

Optional Vena Cava Filters: What, Why, and When

Optional vena cava filters can used to provide either short-term or permanent protection from pulmonary embolism. These devices have recently become available for clinical use in the United States.
Healthline

What Are the Types of Vena Cava Filters?

Vena cava filters may prevent blood clots in your veins from reaching your lungs. They may be permanent, long-term solutions or temporary screens that may be removed after a few weeks or months. The ...
FierceBiotech

J&J's Cordis hit with Class I recall; LDR wins FDA approval for spinal implant;

> Johnson & Johnson's ($JNJ) Cordis received the FDA's most-serious recall tag over a label update the company applied to its Optease retrievable vena cava filter ...
PharmiWeb

The Increasing Value Of The Inferior Vena Cava (IVC) Filter Market By 2035

The Inferior Vena Cava (IVC) filter is a crucial medical device designed to prevent the occurrence of a pulmonary embolism (PE), a condition that can be fatal if untreated. The Inferior Vena Cava (IVC ...